Merck invests $2.9 billion in Pennsylvania for AI and robotics drug research
Merck is spending $2.9 billion to expand its Pennsylvania operations, focusing heavily on a new AI and robotics research facility.
Hiring · Source: Reuters
What happened
Merck is investing $2.9 billion to expand its operations in Montgomery County, Pennsylvania by the end of 2030. A major piece of this is a $550 million investment in a new facility called ADVANCE. This facility will focus on robotics and artificial intelligence for drug research and development. The state is adding a $5 million grant to support the project.
The expansion will take place at Merck's West Point Campus and the nearby Springhouse Innovation Park. The West Point campus already manufactures over 200 million doses of vaccines every year. Company leaders say the new ADVANCE facility represents the future of clinical development. They are investing heavily in scientific capabilities to drive the next generation of medicines.
This move is part of a larger trend in Pennsylvania's life sciences sector. Governor Josh Shapiro noted the state is launching the Innovate in PA 2.0 program with $125 million in funding to support this growth. The state is home to about 3,900 life sciences companies employing over 110,000 people. Other major companies like Johnson & Johnson, Eli Lilly, and GSK are also expanding in the state.
By the numbers
- $2.9 billion — Total investment by Merck to expand operations in Montgomery County by 2030
- $550 million — Amount Merck is spending on the ADVANCE robotics and AI drug research facility
- 110,000 — Number of Pennsylvanians currently employed in the state's life sciences industry
- 200 million — Doses of vaccines manufactured annually at Merck's West Point campus
Why it matters
Traditional pharmaceutical companies are changing how they discover medicines. They are no longer relying solely on traditional lab work. Instead, they are building massive facilities powered by artificial intelligence and robotics. This means the types of roles these companies need are changing. They need engineers and technologists who can build and run these advanced systems.
Tech workers often overlook the pharmaceutical industry. However, this sector is highly stable and heavily funded. When a company commits over half a billion dollars to a single AI facility, it shows a long-term strategy. The integration of robotics will not replace human scientists. Instead, it automates the slowest parts of the discovery process. This requires a new workforce that understands both hardware and software.
Who this hits
AI and robotics engineers
Pharmaceutical companies are spending billions on automated research facilities. This creates direct hiring demand for engineers who can build and maintain these AI models and robotic systems.
Life sciences professionals
The state is investing in clinical trial networks and talent pathways to keep skilled workers. Scientists will increasingly work alongside advanced robotics to speed up drug discovery.
Tech workers facing layoffs
Pennsylvania is actively funding its biotech ecosystem to attract and retain talent. Tech workers can look to the East Coast life sciences sector for stable roles outside of traditional software companies.
New graduates
The state's new Life Sciences Paths Grant Program specifically targets workforce gaps. New graduates in STEM fields will find targeted entry-level opportunities as these companies grow and hire locally.
What to do this week
- Look for open roles at pharmaceutical companies like Merck, Johnson & Johnson, and Eli Lilly if you have an AI or robotics background.
- Search for jobs in Montgomery County and the broader Pennsylvania area, as the state is actively funding talent pathways in life sciences.
- Highlight any experience you have with automation, machine learning, or data science when applying for biotech roles.
- Research the Springhouse Innovation Park and West Point campus areas if you are open to relocating for stable tech roles.
See who's hiring right now on GiraffyReach
My take
I see a clear shift in where tech jobs are heading. Pharma companies are not just hiring scientists anymore; they need AI and robotics engineers to speed up drug discovery. If you have these tech skills, the life sciences sector is a massive, well-funded market you should target.